Loading data for XBI — first visit, this takes a few seconds.

Alert

アラート

State Street SPDR S&P Bio... (XBI)

NYSEArca: XBI · リアルタイム株価 · USD

163.38

-6.17 (-3.64%)

終値時点： Aug 20, 2026, 8:00 PM

164.51

+0.67%

寄り付き前: 5:31 AM

-3.64% (1D)

データがありません

買気配	0
時価総額	n/a
純資産総額	9.63B
基準価額	169.48
ベータ	1.14
EPS（過去12か月）	n/a
PER（過去12か月）	n/a
発行済口数	n/a
設定日	Jan 31, 2006

売気配	0
出来高	15,021,267
平均出来高（20日）	8,938,712
始値	166.66
前日終値	169.55
日中値幅	162.54 - 167.50
52週の値幅	88.60 - 169.68
組入銘柄	n/a
経費率	0.35%

XBIについて

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

資産クラス Equity

ティッカー XBI

設定日 Jan 31, 2006

運用会社 State Street Investment Management

ウェブサイトファンドの公式ページ

取引所 NYSEArca

主なセクター

セクター	構成比 %
Healthcare	99.60%
Financial Services	0.40%

全セクターを見る

上位10銘柄純資産の13.97%

名称	シンボル	構成比
Apogee Therapeutics ...	APGE	1.65%
Oruka Therapeutics I...	ORKA	1.53%
Dianthus Therapeutic...	DNTH	1.42%
Erasca Inc	ERAS	1.38%
Twist Bioscience Cor...	TWST	1.37%
Kymera Therapeutics ...	KYMR	1.34%
Spyre Therapeutics I...	SYRE	1.33%
Revolution Medicines...	RVMD	1.32%
Cg Oncology Inc	CGON	1.32%
Protagonist Therapeu...	PTGX	1.31%

組入銘柄をもっと見る

分配金分配金利回り 0.35%

権利落ち日	金額	支払日
Jun 22, 2026	$0.1380	n/a
Dec 22, 2025	$0.4070	n/a
Sep 22, 2025	$0.0270	n/a
Jun 23, 2025	$0.0070	n/a
Mar 24, 2025	$0.0050	n/a

分配金履歴をすべて見る

ニュース

2日前 · The Wall Street Journal

⚡Flash Heard: Why Healthcare Is Partying Like It’s Late 2020

Moderna and Merck are surging today after the two companies said their experimental mRNA-based treatment succeeded in a late-stage study of high-risk melanoma patients. The SPDR S&P Biotech ETF (XBI)...

2日前 · Barrons.com

Biotech Stocks Are Booming. What This Top Fund Is Buying Now.

Franklin Biotechnology Discovery has a much higher 13% five-year annualized return than a biotech index ETF’s 5.3%

2日前 · Motley Fool

XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?

XBI's lower fees and 155-stock portfolio contrast sharply with FBT's concentrated 30-holding approach, though FBT has experienced less volatility over the past five years.

3日前 · Motley Fool

Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?

PPH offers the income and stability of proven pharmaceutical leaders while XBI swings for the fences across 155 smaller biotech names.

1週間前 · Motley Fool

iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?

XBI surged 80% in one year but endured a 54% drawdown, while IXJ delivered steadier gains with half volatility and a 1.4% dividend.

2ページ中1ページ